Oruka Therapeutics (ORKA) Change in Account Payables (2010 - 2026)
Oruka Therapeutics (ORKA) posted quarterly Change in Account Payables of $3.0 million for Q1 2026, up 157.54% year-over-year from $1.2 million in Q1 2025, and up 162.93% quarter-over-quarter from -$4.8 million in Q4 2025.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Change in Account Payables (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Change in Account Payables history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 157.54% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $2.2 million (up 143.62% YoY), while the FY2025 annual figure was -$6.0 million, down 199.85% from the prior year.
- Change in Account Payables for Q1 2026 stood at $3.0 million, up from -$4.8 million in the prior quarter.
- The five-year high for Change in Account Payables was $6.4 million in Q2 2025, with the low at -$5.2 million in Q1 2025.
- The 5-year median for Change in Account Payables is -$103000.0 (2022), against an average of $132294.1.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables plunged 4216.67% in 2022, then jumped 18121.88% in 2024.
- Oruka Therapeutics' Change in Account Payables stood at -$259000.0 in 2022, then surged by 115.44% to $40000.0 in 2023, then jumped by 10902.5% to $4.4 million in 2024, then sank by 208.13% to -$4.8 million in 2025, then soared by 162.93% to $3.0 million in 2026.
- Business Quant data shows ORKA's Change in Account Payables at $3.0 million in Q1 2026, -$4.8 million in Q4 2025, and -$2.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - | 800,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -111,000.00 |
| Jun 30, 2025 | -698,000.00 |
| Mar 31, 2025 | -5.21 Mn |
| Dec 31, 2024 | -335,000.00 |
| Sep 30, 2024 | -9.08 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 5.83 Mn |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 81,000.00 |
| Jun 30, 2023 | -125,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | -259,000.00 |
| Sep 30, 2022 | -517,000.00 |
| Jun 30, 2022 | 96,000.00 |
| Mar 31, 2022 | -103,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -1.07 Mn |